Health & Science
UR researchers develop new method for liquid biopsies
|
The technique, called CAD-LB, holds promise for rapidly diagnosing cancer and assessing the progress of therapies.
Health & Science
Wilmot Cancer Institute gets $4 million commitment
|
The funds from the Pluta Cancer Foundation will boost recruitment and retention initiatives, and help fund clinical trials.
Health & Science
Saunders to make $30 million gift to URMC
|
The bulk of the commitment to the University of Rochester Medical Center by entrepreneur and philanthropist Philip Saunders will support the work of the UR Medicine Orthopaedics & Physical Performance Center.
Health & Science
UR Medicine to pause some elective, semi-elective surgeries
|
The medical system has taken action in response to a nationwide shortage of intravenous sterile fluids. The pause begins Oct. 16.
Health & Science
The crisis in skilled nursing care
|
For decades, Rochester-area health institutions have struggled to find enough beds for patients who need skilled nursing care. Since COVID, the problem has grown much worse.
Health & Science
Strong Memorial expansion gets local funding boost
|
A $1 million donation from alumnae and business leaders Peter and Kathleen Landers will support the hospital’s ongoing expansion project.
Health & Science
URMC’s post-COVID financial squeeze
|
The University of Rochester Medical Center, whose UR Medicine system is the region’s largest health care provider, is trying to rein in skyrocketing labor costs.
Health & Science
URMC gets another $27 million for heart care study
|
The funds, for the first large-scale, head-to-head comparison of two heart failure drugs, brings to $54 million the total received by the URMC cardiac research team in four months.
Economy & Business
A startup focused on medicinal cannabis quality control
|
CannaMetrix aims to provide medically relevant, biological endpoint metrics for validating the quality and potency of cannabis products.
Health & Science
A blow to safety net providers
|
Since the state’s takeover of the Medicaid prescription drug program last year, safety net hospitals and clinics—those serving Medicaid, uninsured and underinsured patients—have been reeling from the loss of drug company discounts.